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Nitrosopeptide Mapping: A Novel Methodology
Reveals S-Nitrosylation of Dexras1
on a Single Cysteine Residue
protein function or activity, as was first shown with the
N-methyl-D-aspartate (NMDA) receptor [4].
The nitrosothiol modification can be detected by het-
erolytic cleavage of the S-NO bond by HgCl2, followed
by colorimetric or fluorometric detection of NO2 that
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Nitrosothiol modification of cysteines blocks its ability
to react with biotinylmaleimide derivatives, thus allowing
the presence of nitrosothiols to be inferred by the reduc-
Summary tion in the labeling of protein compared to a non-S-
nitrosylated control [6]. In practice, it is difficult to detect
S-Nitrosylation of specific cysteine residues is a re- a slight reduction in the labeling of a S-nitrosylated pro-
versible signaling mechanism of nitric oxide (NO) gen- tein compared to its unmodified control if only one or a
erated by NO synthase (NOS) enzymes. In some pro- few of its cysteines is S-nitrosylated.
teins, evidence has accumulated that more than one We have described the labeling of S-nitrosylated pro-
cysteine can be S-nitrosylated; however, it is difficult teins with biotin specifically on S-nitrosylated cysteines
to distinguish S-nitrosylation on separate cysteine res- [7]. Labeling allows S-nitrosylated proteins to be readily
idues. We report a novel simple, sensitive, and specific detected by biotin immunoblotting and allows S-nitro-
procedure for nitrosopeptide mapping. Dexras1 is a sylated proteins to be purified by avidin-affinity chroma-
monomeric G protein whose guanine nucleotide ex- tography. Labeling is achieved in three steps. In the first
change activity is augmented by NO; the identity and step, free thiols in a protein or a protein mixture are
number of its S-nitrosylated cysteines is unknown. We blocked by incubation with the thiol-specific methylthio-
describe the radiolabeling of S-nitrosylated cysteine lating agent methyl methanethiosulfonate (MMTS) [8].
residues in Dexras1. A nitrosopeptide map, generated Sodium dodecyl sulfate (SDS) is used as a protein dena-
by two-dimensional peptide chromatography, reveals turant to ensure access of MMTS to buried cysteines.
that only a single cysteine is S-nitrosylated following Under the conditions used, MMTS does not react with
NO exposure. Mutagenesis of Cys11 abolished the ef- nitrosothiols [7] or preexisting disulfide bonds [8]. The
fect of NO donors on Dexras1, implicating this residue procedures are performed in the dark to minimize pho-
in the NO-mediated activation of Dexras1. tolysis of the nitrosothiol bonds. In the second step,
nitrosothiol bonds are selectively decomposed with
ascorbate, which results in the reduction of nitrosothiolsIntroduction
to thiols [9, 10]. In the third step, the newly formed
thiols are reacted with N-[6-(biotinamido)hexyl]-3-(2-Nitric oxide (NO) is a highly reactive signaling molecule
pyridyldithio)propionamide (biotin-HPDP), a sulfhydryl-that is made in a wide variety of cells, most prominently:
specific biotinylating reagent [11]. Because MMTS canneurons, skeletal muscle, endothelial cells, and certain
compete with biotin-HPDP for thiol groups, residualimmune system cells. In these cells, NO is synthesized
MMTS is removed by desalting on a spin column or byby one or more of three highly related NO synthase
acetone precipitation prior to treatment with ascorbate.(NOS) isoenzymes, each of which is encoded by a sepa-
By the end of the third step, S-nitrosylated proteins arerate gene and named for the initial cell type in which it
labeled with biotin specifically on cysteine residues thatwas isolated. These enzymes, neuronal NOS (nNOS),
were once S-nitrosylated.endothelial NOS (eNOS), and macrophage or inducible
This technique has provided insight into the nitroso-NOS (iNOS), synthesize NO from arginine and NADPH
proteome. In a screen designed to identify S-nitrosyl-in an O2-dependent reaction. One pathway by which
ated proteins in the brain [7], several proteins were iden-NO signals is by the formation of nitrosothiols [1, 2], a
tified, including the NR2A and NR1 subunits of the NMDAmodification of the thiol moiety on cysteine residues,
receptor, GAPDH, the sodium-potassium ATPase, actin,also called S-nitrosation or S-nitrosylation. The forma-
and the retinoblastoma gene product (Rb) [7]. Endoge-tion of nitrosothiols appears to require the reaction of
nous S-nitrosylation of these proteins is abolished inNO with O2, resulting in oxidizing NOx (such as NO2 and
mice harboring a targeted deletion of nNOS [7], estab-N2O3) that serve as the direct oxidizing species that
lishing that neurally-generated NO mediates the S-nitro-S-nitrosylate cysteines [3]. S-Nitrosylation can modulate
sylation of these proteins.
Although S-nitrosylation appears to be a relatively
specific reaction that occurs only on one or a few cys-5 Correspondence: ssnyder@jhmi.edu
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teines within a given protein, mechanisms underlying
the selectivity of S-nitrosylation have been unclear. By
analogy with kinase signaling, a consensus sequence
for S-nitrosylation has been proposed, based on the
idea that amino acids adjacent to a cysteine may con-
tribute to its ability to be S-nitrosylated [12].
Alternatively, S-nitrosylation may be facilitated by di-
rect juxtaposition of NOS with a S-nitrosylation target.
We discovered that nNOS binds selectively to CAPON
[13], an adaptor protein that can physically couple nNOS
to physiologic targets [14, 15]. CAPON binds to a re-
cently discovered monomeric G protein, Dexras1, re-
sulting in the formation of a ternary complex comprising
nNOS, CAPON, and Dexras1. A mechanism for activa-
tion of Dexras1 was suggested by analogy with H-ras,
a highly similar G protein that is activated by NOS en-
zymes [16, 17, 18], and can be S-nitrosylated [19]. In-
deed, Dexras1 is also activated by nNOS [14]. This acti-
vation is greatly enhanced by the presence of CAPON and
the concomitant formation of the ternary complex [14].
Although H-ras is S-nitrosylated on Cys-118 [20], there
is no cysteine in the corresponding position of Dexras1.
Figure 1. S-Nitrosylation of Dexras1 by Different NO DonorsThus, the S-nitrosylated cysteine(s) in Dexras1 are un-
(A) S -Nitrosylation of Dexras1 detected by the biotin-swap method.known. Proteins vary in the number of cysteines that
Dexras1 and GST were prepared in E. coli, purified by glutathione-
are S-nitrosylated with some, such as the ryanodine affinity chromatography, and then dialyzed to remove free glutathi-
receptor, possessing several cysteines that are S-nitro- one. Proteins were incubated with 100 M SNAP, an NO donor, or
sylated [21], whereas caspase-9 and H-ras are S-nitro- the control compound NAP. Following the biotin-swap, S-Nitrosyla-
tion was detected by anti-biotin Western blot. GST-Dexras1 wassylated on single cysteine residues [19, 22]. To identify
S-nitrosylated, while the control protein GST was not appreciablyspecific cysteines that are S-nitrosylated in Dexras1, we
S-nitrosylated under the conditions used.have developed an approach analogous to phospho-
(B) S-nitrosylation of Dexras1 by GSNO in a HEK293 lysate. HEK293
peptide mapping termed nitrosopeptide mapping. We cells were transfected with a plasmid, resulting in the expression
have modified the biotin-HPDP reagent employed in our of myc-Dexras1. Lysates were treated with 100 M GSNO or GSH
S-nitrosylation method [7], replacing the biotin with an and subjected to the biotin-swap method. Biotinylated proteins were
purified on neutravidin agarose and then eluted with 2-ME. Myc-[35S]-labeled tag. Utilizing this reagent, we demonstrate
Dexras1 was detected in lysates treated with GSNO, but not lysatesthat Dexras1 is S-nitrosylated on a single cysteine. Mu-
treated with GSH. The lower panel shows the expression of myc-tagenesis of cysteine-11 abolishes NO-dependent acti-
Dexras1 in the HEK293 lysates.
vation of its guanine nucleotide exchange activity, impli-
cating this residue in NO-dependent activation.
S-Nitrosoglutathione (GSNO) is present in tissues at
micromolar concentrations and might serve as an en-Results
dogenous reservoir of NO groups [2, 23]. GSNO is struc-
turally related to SNAP and is also a nitrosothiol NODexras1 Is S-Nitrosylated by Distinct NO Donors
donor. To determine if Dexras1 can be S-nitrosylated bySeveral lines of evidence suggest that Dexras1 is
GSNO, we examined the ability of GSNO to S-nitrosylateS-nitrosylated by NO. First, like H-Ras, the guanine nu-
myc-Dexras1 in cellular lysates. HEK293 cells werecleotide exchange activity of Dexras1 is activated by
transfected with a myc-Dexras1-expressing plasmidNO donors [14], as well as by cotransfection of Dexras1
[14], and lysates were incubated with GSNO or glutathi-and nNOS in HEK293 cells [14]. NO donors can activate
one (GSH). Lysates were then subjected to the biotin-purified Dexras1, and activation of Dexras1 in HEK293
swap method [7, 24], and the biotinylated proteins werecells by nNOS is not blocked by guanylyl cyclase inhibi-
purified on neutravidin agarose. The biotin adduct istors nor is it activated by cell-permeable nonhydrolyz-
connected to the protein via a disulfide bond, allowingable cGMP analogs [14], ruling out a role for the guanylyl
bound proteins to be eluted from the neutravidin-aga-cyclase pathway in the activation of Dexras1.
rose with 2-mercaptoethanol (2-ME). 2-ME eluates de-To determine if Dexras1 is S-nitrosylated by NO do-
rived from lysates treated with GSNO contained myc-nors, we incubated 100 ng GST-Dexras1 with 100 M
Dexras1 (Figure 1B), while 2-ME eluates from lysatesS-nitroso-N-acetylpenicillamine (SNAP), a nitrosothiol
treated with GSH did not contain myc-Dexras, indicatingNO donor, or 100 M N-acetylpenicillamine (NAP), its
that Dexras1 is S-nitrosylated by GSNO in the contextinactive control. Nitrosylated cysteine residues were bi-
of a cellular lysate.otinylated using the biotin-swap method [7]. SNAP-
treated GST-Dexras1 was readily labeled, while biotiny-
lation of NAP-treated GST-Dexras1 was not detectable Radioactive Labeling of S-Nitrosylated Dexras1
Specific labeling of S-nitrosylated cysteines requires the(Figure 1A). GST is not readily S-nitrosylated under these
conditions (Figure 1A). formation of a detectable adduct by reaction with a thiol-
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Figure 2. Synthesis and Purification of [35S]APDP
(A) [35S]APDP was prepared by a disulfide exchange reaction be-
tween [35S]cysteine and 2,2-dithiodipyridine.
(B) [35S]APDP thin-layer chromatography indicated essentially com-
plete formation of the product. Unreacted dithiodipyridine, mercap-
topyridine, and reduced and oxidized DTT were visualized under
UV light and migrated to the positions shown.
Figure 3. Radiolabeling of S-Nitrosylated Proteins
Schematic diagram of radiolabeling procedure. A theoretical protein
is indicated with cysteine thiols present in either the thiol, disulfide,
specific sulfhydryl reagent after reduction of nitrosothi- and nitrosothiol state. In the first step, MMTS is used to rapidly
oxidize thiols, resulting in the essentially complete methylthiolationols with ascorbic acid. In our original report, we labeled
of cysteines in the protein sample. SDS is used to ensure accessreduced nitrosocysteines with the activated mixed disul-
of the MMTS reagent to buried thiols. MMTS is removed by precipita-fide compound biotin-HPDP. This compound contains
tion of proteins with acetone and then nitrosothiols are selectivelya mixed pyridyl disulfide, a reactive group that is specific
reduced with ascorbate, resulting in the regeneration of cysteines
for thiols [11]. We developed an analogous compound only at residues that were once S-nitrosylated. [35S]APDP, an acti-
comprising an identical activated mixed pyridyl disul- vated mixed disulfide, reacts with these thiols to confer an amino-
propionic acid adduct to cysteines. The radioactive isotope is indi-fide, as well as a radioactive tag in place of the biotin
cated (*).tag used in biotin-HPDP. This compound, [35S]-2-amino-
3-(2-pyridyldithio)-propionate (APDP), was chosen for
synthesis because it utilizes a precursor, cysteine
treated with GSNO, but not GSH (Figure 4A), confirming(2-amino-3-thiopropionic acid), which is readily avail-
the specificity of the procedure for S-nitrosylatedable in radioactive form. Synthesis of the target com-
Dexras1.pound was achieved by reaction of dithiodipyridine with
cysteine (Figure 2A). TLC revealed complete incorpora-
tion of [35S]cysteine into the product APDP (Figure 2B). Nitrosopeptide Mapping of S-Nitroso-Dexras1
S-nitroso-Dexras1 was prepared by incubation of the Inspection of the rat Dexras1 sequence indicates that
GST-tagged fusion protein with 100M GSNO or 100M there is no predicted tryptic peptide from Dexras1 that
GSH for 30 min. After in vitro S-nitrosylation, remaining
GSNO or GSH was removed by desalting the protein
twice on a spin column. To radiolabel nitrosylated cys-
teines, Dexras1 fusions were subjected to the biotin-
swap assay as before, except [35S]APDP was used in
place of biotin-HPDP (Figure 3). In the first step, unmodi-
fied thiols in S-nitroso-Dexras1 were blocked by the
addition of MMTS in the presence of SDS at 50C for
20 min, conditions that we have previously found to
methylthiolate essentially all thiols in a protein sample
[7]. Next, protein was precipitated with acetone and
resuspended, and nitrosothiols were reduced with
ascorbic acid for 1 hr. Lastly, newly formed thiols were
reacted with [35S]APDP, resulting in the addition in a
Figure 4. Radiolabeling and Nitrosopeptide Mapping of Dexras1[35S] aminothiopropionate adduct on cysteines that were
(A) Radiolabeling of S-nitroso-Dexras1. Purified Dexras1 was incu-once S-nitrosylated (Figure 3). This adduct is a cysteine,
bated with GSH or GSNO as indicated and then radiolabeled onresulting in the formation of a cysteine dimer, i.e., cys-
modified cysteine residues with [35S]APDP. Only Dexras1 treated
tine, with the 35S radiolabel in the adduct. Because the with GSNO was detectably labeled by autoradiography.
radioactive tag is connected to the protein via a disul- (B) S-nitroso-Dexras1 nitrosopeptide map. After purification of the
radiolabeled protein by electroblotting to nitrocellulose and excision,fide, reducing agents (such as 2-ME or DTT) were ex-
[35S]Dexras1 was trypsinized and tryptic peptides were resolved bycluded from all subsequent steps.
two-dimensional peptide mapping. Peptides were subjected to elec-Radiolabeled protein was separated from unincorpo-
trophoresis in the x axis and ascending chromatography in the y axis.rated [35S]APDP by SDS-PAGE. Protein was transferred
Autoradiography revealed a single prominent spot consistent with a
to a nitrocellulose membrane, which was then exposed single site of S-nitrosylation. There are no predicted tryptic peptides
to autoradiography film to locate the radiolabeled pro- from Dexras1 that contain more than one cysteine residue, indicat-
ing that only one cysteine is S-nitrosylated.tein. Radioactive protein was only detected in samples
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previously performed to identify the site of S-nitrosyla-
tion in H-ras [19].
Discussion
Previously, we described a technique for identifying en-
dogenously S-nitrosylated proteins [7]. In the present
study, we have modified this technique to provide a
simple, sensitive, and specific method for nitrosopep-
Figure 5. Mutation of Cys11 Prevents NO-Induced Activation of
tide mapping, enabling investigators to pinpoint a spe-Dexras1
cific amino acid that is S-nitrosylated. This method reliesThe guanine nucleotide exchange activity of each GST-Dexras1
on the use of [35S]APDP, a mixed pyridyl disulfide, tomutant was measured following incubation with an NO donor, SNAP,
specifically modify cysteines that are produced by re-and the control compound NAP. The C11S mutant shows no in-
crease in activity following SNAP treatment relative to NAP. Wild- duction of nitrosocysteine. In analogy to the heuristic
type Dexras1 (WT) and other Cys→Ser mutants showed between utility of phosphopeptide mapping, the present tech-
2.0- to 2.8-fold increases in activity following incubation with SNAP. nique should enhance research into S-nitrosylation as
Data are presented as means SEM of three to four separate mea-
a physiologic means of NO signaling by enabling re-surements.
searchers to monitor the S-nitrosylation of different cys-
teines simultaneously. In addition to its use in nitroso-
peptide mapping, the [35S]-swap method may have otherwould have more than one cysteine in it (S.R.J., M.F.,
and S.H.S., unpublished data). Thus, the number of uses. For example, because the degree of incorporation
of 35S can be measured by scintillation counting, thespots seen in a peptide mapping experiment would indi-
cate the number of labeled cysteines in Dexras1. To [35S]-swap method may prove useful in experiments in
which quantitation of S-nitrosylation is desired. We haveprepare tryptic fragments, the portion of the nitrocellu-
lose membrane containing the protein was subjected to applied this technique to Dexras1 and determined that
a single cysteine is preferentially S-nitrosylated in re-trypsinolysis [25]. The radioactive peptide solution was
spotted onto cellulose TLC plates and subjected to elec- sponse to NO donors. Mutagenesis experiments impli-
cates Cys11 in the activation of this G protein, sug-trophoresis in the x axis followed by ascending chroma-
tography. Autoradiography of the TLC plate revealed a gesting that Dexras1 and H-ras are activated by NO in
a different manner.single major spot suggestive of a single radiolabeled
peptide (Figure 4B), indicating that only one cysteine is The finding that only one cysteine in Dexras1 is
S-nitrosylated is not surprising given the high degree ofS-nitrosylated in Dexras1.
selectivity in S-nitrosylation reactions characterized so
far. For example, the NMDA receptor NR2A subunit isIdentification of Cysteine-11 as the Target of
S-Nitrosylation in Dexras1 S-nitrosylated on Cys-399 [26], and caspase-3 is S-nitro-
sylated on Cys-163 [22], although each of these proteinsDexras1 contains seven cysteines of which one, C-276,
at the extreme C terminus, is palmitoylated and thus have numerous other cysteine residues. Presumably,
the key feature that determines the likelihood of S-nitro-not a likely candidate for S-nitrosylation. To identify the
S-nitrosylated cysteine in Dexras1, we mutagenized the sylation is the degree of reactivity of the thiol. The reac-
tivity of a cysteine is a function of its nucleophilicity andother six cysteines to serine and monitored the guanine
nucleotide exchange activity of the mutant GST-Dexras1 is reflected by its pKa. This can be regulated by hydrogen
bonding interactions of amino acids adjacent to the cys-fusion proteins. In these experiments, Dexras1 was ini-
tially treated with unlabeled GDP to saturate the nucleo- teine (in either the primary or tertiary protein structure)
with the proton in the thiol moiety, resulting in dramati-tide binding sites in Dexras1. After removal of GDP, the
proteins were treated with either 50 M SNAP or NAP cally reduced pKas and substantially increased nucleo-
philicity. Indeed, based on S-nitrosylation sites previouslyfor 30 min to activate the protein’s intrinsic guanine
nucleotide exchange activity. The protein mixture was identified, Stamler and associateshave proposed that resi-
dues adjacent to cysteines capable of being S-nitro-treated with [35S]GTP--S to label vacant Dexras1 nucle-
otide binding sites. sylated form such hydrogen bonding interactions, and
they have suggested a possible consensus motif forAs observed previously [14], SNAP treatment of wild-
type Dexras1 augmented binding 2- to 3-fold relative to S-nitrosylation [12]. This motif is characterized by hydro-
philic residues adjacent to the S-nitrosylated cysteine:control. Dexras1 mutants containing mutations at cys-
teines 24, 123, 145, 171, or 224 retained an NO-depen- X-Y-C-Z, where X  G, S, T, C, Y, or N; Y  K, R, H, D,
or E; and Z  D or E. In Dexras1, the three residuesdent enhancement of guanine nucleotide exchange (Fig-
ure 5). By contrast, augmentation of [35S]GTP--S immediately N-terminal to Cys-11 are Lys-Lys-Met. Con-
ceivably, the lysines contribute to the nucleophilicity ofbinding by SNAP was abolished when Cys-11 was muta-
genized to serine (Figure 5). Our finding that Cys-11 is Cys-11. Alternatively, the nucleophilicity of the thiol may
be regulated by residues that are brought into proximityrequired for activation of guanine nucleotide exchange
by Dexras1 is consistent with the possibility that Cys- to the cysteine as a consequence of the three-dimen-
sional conformation of the protein.11 is S-nitrosylated. Definitive evidence for S-nitrosyla-
tion of this residue could be obtained by mass spectro- The physical coupling of Dexras1 to nNOS via CAPON
may allow Dexras1 to have a lower reactivity towards NOmetric analysis of Dexras1-derived peptides, as was
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reaction was allowed to incubate for 15 min at 25C, at which pointthan other proteins such as H-ras, which is not known to
the APDP was precipitated by the addition of 9 ml acetone (20C).be physically coupled to a NOS protein. In this way,
The precipitate was collected by centrifugation and washed twoNO-mediated activation of Dexras1 could be limited to
more times in acetone and then dried by rotary evaporation to yield
cases in which Dexras1 is present in the nNOS ternary a pale yellow oil. The product was greater than 99% pure by HPLC.
complex, reducing the likelihood of spurious activation MS (ESI) 231.0 [M  H]. This material comigrated on TLC with
[35S]APDP, confirming the identity of the radioactive product.of unbound Dexras1 by ambient NO or by NO produced
in another signaling event and allowing NO signaling to
Biotinylation of S-Nitrosylated Dexras1 and H-RasDexras1 to be compartmentalized.
The biotin-swap to label S-nitrosylated cysteine residues was per-It is notable that Dexras1 lacks a cysteine correspond-
formed as described previously [7, 24]. In brief, GST-Dexras1 and
ing to the S-nitrosylated cysteine in H-ras, Cys-118 [20], GST-H-ras were prepared as before [14] and incubated with the
indicating that a different cysteine must account for the indicated concentrations of NO donor or control and then desalted
effects of NO on Dexras1. Indeed, Dexras1 is S-nitrosyl- two times on a spin column to remove residual NO donor. The
proteins were then incubated with 20 mM MMTS in the presenceated at Cys-11, which is present in an approximately 40
of SDS, the metal chelators neocuproine and EDTA. After methylthi-amino acid-long, N-terminal portion of Dexras1 that is
olation of the protein thiols by MMTS, nitrosothiols were decom-not found in other ras-like proteins including H-ras. De-
posed with ascorbate, and the thiols that formed as a result of
spite the difference in the location of the S-nitrosylated ascorbate treatment were labeled with biotin-HPDP (Pierce, Rock-
residues in these two proteins, both S-nitrosylation ford, IL). Biotinylated proteins were detected with a biotin-specific
events activate their respective ras proteins by increas- antibody.
For experiments studying myc-Dexras1 in HEK293 lysates, myc-ing the dissociation rate of GDP [14, 16]. In the case of
Dexras1 was expressed in HEK293 cells as described previouslyDexras1, the role of the N-terminal domain in which Cys-
[14], and cells were sonicated in HEK buffer. Lysates were then11 lies is not known, although conceivably S-nitrosyla-
centrifuged at 14,000 	 g for 10 min at 4C, and the supernatants
tion induces a conformational change in the protein, were used in subsequent experiments. Lysates (0.8 g protein/ml)
which enhances dissociation of GDP. were incubated with the indicated concentrations of GSH or GSNO
for 10 min at 25C in the dark and then subjected to the biotin-swap
as described above. Biotinylated proteins were then precipitatedSignificance
with 2 volumes acetone at 20C for 30 min and then recovered
by centrifugation at 14,000 	 g for 10 min at 4C. The pellet wasS-Nitrosylation is a dynamic modification that may oc-
resuspended and incubated with 100 l neutravidin agarosecur on multiple cysteines within a given protein. In (Pierce), washed extensively with wash buffer (500 mM NaCl, 1 mM
studies of protein phosphorylation, phosphopeptide EDTA, 20 mM HEPES [pH 7.7]), and the bound proteins were eluted
mapping has proved to be an invaluable tool to study with 0.1X HEN buffer containing 100 mM 2-ME. The 2-ME eluates
were separated by SDS-PAGE and blotted with an anti-myc antibodythe dynamics of phosphorylation at distinct residues.
(Oncogene Sciences) to detect myc-Dexras1.The methodology described here will allow the stoichi-
ometry and dynamics of S-nitrosylation to be readily
Radiolabeling Nitrosothiolsestablished. The S-nitrosylation of Dexras1 on a single
GST-Dexras1 was prepared in E. coli, bound to glutathione agarose,
cysteine residue identifies a single residue responsible and eluted with 10 mM glutathione as described [14]. Glutathione
for activation of its guanine nucleotide exchange activ- was removed by dialysis and then equilibrated in HEN buffer (250
ity and suggests a role for its N-terminal domain in mM HEPES [pH 7.7], 1 mM EDTA, 0.1 mM neocuproine). GST-Dex-
ras1 was incubated with 50 M GSNO or 50 M GSH for 1 hr atthe regulation of its biological activity.
room temperature in the dark. The GSH or GSNO was removed by
passing the mixture through a spin column as above.Experimental Procedures
Fusion proteins were incubated in HEN buffer to a final concentra-
tion of 0.8 g protein per ml based on the BCA protein assay. ToSynthesis of [35S]-APDP
this solution were added four volumes of blocking buffer (9 volumes2-Amino-3-(2-pyridiyldithio)-propionic acid was synthesized by
of HEN buffer plus 1 volume 25% SDS, adjusted to 20 mM MMTSadding 10 l [35S] cysteine (Perkin-Elmer, Boston, MA, 11 mCi/ml,
with a 2 M stock prepared in dimethylformamide) at 50C for 20 min1075 Ci/mmol) containing 10 mM DTT (already present in the com-
in the dark with frequent vortexing. The MMTS was then removedmercial preparation) to 10l of 50M 2,2-dithiodipyridine in metha-
by precipitation with 2.5 volumes of 20C acetone for 30 minnol. To this solution was added 10 l phosphate-buffered saline,
at 20C. The protein was recovered by centrifugation at 14,000 	and this reaction was incubated for 60 min at 25C. To this reaction
g for 10 min at 4C. The pellet was resuspended in 50 l 0.1X HENwas added 10 l 10:1 methanol:HOAc, and the mixture was spotted
buffer containing 1% SDS. To this sample was added 2 	 107 cpmonto an analytical silica TLC plate and resolved using 12:6:1:1
[35S]APDP in a volume of 50 l and 4 l of 25 mM sodium ascorbate,(CHCl3:MeOH:HOAc:H2O). APDP was localized by apposing the TLC
and the protein was labeled for 1 hr at 25C. In trial experiments,plate to X-OMAT Kodak film for 5 s at room temperature and aligning
further incubation did not result in increased labeling (S.R.J. andthe resulting spot on the film to the TLC plate. APDP migrated to
S.H.S., unpublished data), suggesting that the reaction was essen-an Rf 0.4 and was clearly separated from reduced and oxidized
tially complete, consistent with earlier observations regarding theDTT, which are included in the commercial cysteine stock, as well as
rapid reaction rates of mixed pyridyldisulfides [11]. After incubation,from the unreacted dithiodipyridine and stoichiometrically produced
SDS-PAGE sample buffer was added, and the samples were re-mercaptopyridine. The region of the plate containing the radioactive
solved by SDS-PAGE and transferred to nitrocellulose. Labeled pro-material was scraped, and the silica was resuspended in 75 l
teins were visualized by autoradiography and processed for nitroso-resuspension buffer (25 mM Hepes (pH 7.7); 0.1 mM EDTA, 0.01
peptide mapping as described below. All steps preceding [35S]APDPmM neocuproine). After incubation at 25C for 10 min with frequent
labeling were performed in the dark.vortexing, the silica slurry was clarified by centrifugation. The re-
sulting supernatant contained 80% of the APDP as determined
by scintillation counting. Nitrosopeptide Mapping
[35S]-labeled Dexras1 was separated from unincorporated [35S]APDPTo verify the identity of [35S]APDP, a nonradioactive APDP stan-
dard was prepared. To a solution of 2,2-dithiodipyridine (8.8 mg, by SDS-PAGE. [35S]-Dexras1 was electroblotted onto nitrocellulose
(Biorad), and the location of the protein was detected by autoradiog-40 mol) in 300 l EtOH were added 500 l H2O, 100 l 1 M HEPES
(pH 7.7), and 100 l cysteine hydrochloride (6.3 mg, 36 mol). The raphy. The region of the nitrocellulose containing Dexras1 was ex-
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